BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chekol Abebe E, Mengie Ayele T, Tilahun Muche Z, Asmamaw Dejenie T. Neuropilin 1: A Novel Entry Factor for SARS-CoV-2 Infection and a Potential Therapeutic Target. Biologics 2021;15:143-52. [PMID: 33986591 DOI: 10.2147/BTT.S307352] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Bortolotti D, Simioni C, Neri LM, Rizzo R, Semprini CM, Occhionorelli S, Laface I, Sanz JM, Schiuma G, Rizzo S, Varano G, Beltrami S, Gentili V, Gafà R, Passaro A. Relevance of VEGF and CD147 in different SARS-CoV-2 positive digestive tracts characterized by thrombotic damage. FASEB J 2021;35:e21969. [PMID: 34822202 DOI: 10.1096/fj.202100821RRR] [Reference Citation Analysis]
2 Khoreva MA. [Postcovid syndrome - a new reality]. Zh Nevrol Psikhiatr Im S S Korsakova 2021;121:131-7. [PMID: 34874668 DOI: 10.17116/jnevro2021121101131] [Reference Citation Analysis]
3 Chapoval SP, Keegan AD. Perspectives and potential approaches for targeting neuropilin 1 in SARS-CoV-2 infection. Mol Med 2021;27:162. [PMID: 34961486 DOI: 10.1186/s10020-021-00423-y] [Reference Citation Analysis]
4 Soldevila B, Puig-Domingo M, Marazuela M. Basic mechanisms of SARS-CoV-2 infection. What endocrine systems could be implicated? Rev Endocr Metab Disord 2021. [PMID: 34333732 DOI: 10.1007/s11154-021-09678-6] [Reference Citation Analysis]